A review of cost of illness in Alzheimer’s research
Abstract
Keywords
Full Text:
PDFReferences
Salloway S, Correia S. Alzheimer disease: time to improve its diagnosis and treatment. Cleve Clin J Med. 2009;76(1):49-58.
Sevilla C, Jimenez Caballero PE, Alfonso V, Gonzalez-Adalid M. Current treatments of Alzheimer disease: are main caregivers satisfied with the drug treatments received by their patients? Dement Geriatr Cogn Disord. 2009;28(3):196-205.
Jia J, Wei C, Chen S, et al. The cost of Alzheimer's disease in China and re-estimation of costs worldwide. 2018;14(4):483-491.
Dodel R, Belger M, Reed C, et al. Determinants of societal costs in Alzheimer's disease: GERAS study baseline results. 2015;11(8):933-945.
Aajami Z, Kebriaeezadeh A, Nikfar S. Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran. 2019;18(1):7-12.
Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients. Alzheimers Dement. 2011;7(3):318-327.
Olazarán J, Agüera-Ortiz L, Argimón JM, et al. Costs and quality of life in community-dwelling patients with Alzheimer's disease in Spain: Results from the GERAS II observational study. 2017;29(12):2081-2093.
Byford S, Torgerson DJ, Raftery J. Economic note: cost of illness studies. BMJ (Clinical research ed). 2000;320(7245):1335.
Leicht H, Heinrich S, Heider D, et al. Net costs of dementia by disease stage. 2011;124(5):384-395.
Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327-337.
Darba J, Kaskens L, Lacey L. Relationship between global severity of patients with Alzheimer's disease and costs of care in Spain; Results from the co-dependence study in Spain. 2015;16(8):895-905.
Bloom BS, de Pouvourville N, Straus WL. Cost of illness of Alzheimer's disease: How useful are current estimates? 2003;43(2):158-164.
Doran C. Critique of an Economic Evaluation Using the Drummond Checklist. Applied health economics and health policy. 2010;8:357-359.
Jonsson L, Eriksdotter Jonhagen M, Kilander L, et al. Determinants of costs of care for patients with Alzheimer's disease. 2006;21(5):449-459.
Mesterton J, Wimo A, By A, Langworth S, Winblad B, Jonsson L. Cross sectional observational study on the societal costs of Alzheimer's disease. 2010;7(4):358-367.
Wimo A, Reed CC, Dodel R, et al. The GERAS Study: a prospective observational study of costs and resource use in community dwellers with Alzheimer's disease in three European countries--study design and baseline findings. J Alzheimers Dis. 2013;36(2):385-399.
Lopez-Bastida J, Serrano-Aguilar P, Perestelo-Perez L, Oliva-Moreno J. Social-economic costs and quality of life of Alzheimer disease in the Canary Islands, Spain. 2006;67(12):2186-2191.
Zhu CW, Scarmeas N, Torgan R, et al. Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease. Neurology. 2006;67(6):998-1005.
Joyce AT, Zhao Y, Bowman L, Flynn JA, Carter CT, Ollendorf DA. Burden of illness among commercially insured patients with Alzheimer's disease. 2007;3(3):204-210.
Kraft E, Marti M, Werner S, Sommer H. Cost of dementia in Switzerland. 2010;140:w13093